Delivery Order SPE2DR25D6028-SPE2DR26FAQZM
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ketamine 500 mg/5 mL vials with a ceiling value of $2,756.87. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 22, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ketamine 500mg/5mL in quantities of 10, with a ceiling value of $1,076.58 and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.84 for Ketamine 500mg/5ml (10 units) on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,095.60 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ketamine 500 mg/5 mL vials. This firm fixed price contract, with an ultimate completion date of September 4, 2025, represents a non-set-aside competitive award for pharmaceutical delivery to support federal medical procurement needs. The product will be sourced and distributed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ketamine 500mg/5mL in quantities of 10 units, with a ceiling value of $1,596.56. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, and utilizes firm fixed-price pricing under a non-competitive, non-set-aside delivery order contract type. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ketamine 500 mg/5 mL vials with a ceiling value of $1,187.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively rendered. The contract is expected to reach ultimate completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ketamine 200 mg/20 mL vials with a firm fixed price ceiling value of $4,030.92. The contract, designated as a non-set-aside competitive award, specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ketalar (ketamine) 200 mg/20 ml vials with a ceiling value of $1,228.00. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,968.20 to AmerisourceBergen Drug Corp for the supply of Ketamine 200 mg/20 ml vials. This non-competitive, firm fixed-price delivery order was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,024,939 units of Ketamine 500 mg/5 ml vial, 5 ml, at a ceiling value of $1,156.20. The contract is a firm fixed-price delivery order with an ultimate completion date of October 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FAQZMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ketamine 500mg/5mL in a quantity of 10 units, with a ceiling value of $1,161.03. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the open competition process through which AmerisourceBergen was selected. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle, which enables the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/28/25 |